Skip Nav Destination
MRD negativity as a surrogate for PFS in CLL?
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
Issue Archive
March 1 2018
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
MRD negativity as a surrogate for PFS in CLL?
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
Clinical Trials & Observations
Natalie Dimier,Paul Delmar,Carol Ward,Rodica Morariu-Zamfir,Günter Fingerle-Rowson,Jasmin Bahlo,Kirsten Fischer,Barbara Eichhorst,Valentin Goede,Jacques J. M. van Dongen,Matthias Ritgen,Sebastian Böttcher,Anton W. Langerak,Michael Kneba,Michael Hallek
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome
Dorota M. Rowczenio,Shelly Pathak,Juan I. Arostegui,Anna Mensa-Vilaro,Ebun Omoyinmi,Paul Brogan,Dan Lipsker,Thomas Scambler,Roger Owen,Hadija Trojer,Anna Baginska,Julian D. Gillmore,Ashutosh D. Wechalekar,Thirusha Lane,Rene Williams,Taryn Youngstein,Philip N. Hawkins,Sinisa Savic,Helen J. Lachmann
LYMPHOID NEOPLASIA
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Brief Report
Karen L. Bride,Tiffaney L. Vincent,Soo-Yeon Im,Richard Aplenc,David M. Barrett,William L. Carroll,Robin Carson,Yunfeng Dai,Meenakshi Devidas,Kimberly P. Dunsmore,Tori Fuller,Tina Glisovic-Aplenc,Terzah M. Horton,Stephen P. Hunger,Mignon L. Loh,Shannon L. Maude,Elizabeth A. Raetz,Stuart S. Winter,Stephan A. Grupp,Michelle L. Hermiston,Brent L. Wood,David T. Teachey
PLATELETS AND THROMBOPOIESIS
Nbeal2 interacts with Dock7, Sec16a, and Vac14
Louisa Mayer,Maria Jasztal,Mercedes Pardo,Salvadora Aguera de Haro,Janine Collins,Tadbir K. Bariana,Peter A. Smethurst,Luigi Grassi,Romina Petersen,Paquita Nurden,Rémi Favier,Lu Yu,Stuart Meacham,William J. Astle,Jyoti Choudhary,Wyatt W. Yue,Willem H. Ouwehand,Jose A. Guerrero
RED CELLS, IRON, AND ERYTHROPOIESIS
Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia
Kristin P. Guilliams,Melanie E. Fields,Dustin K. Ragan,Cihat Eldeniz,Michael M. Binkley,Yasheng Chen,Liam S. Comiskey,Allan Doctor,Monica L. Hulbert,Joshua S. Shimony,Katie D. Vo,Robert C. McKinstry,Hongyu An,Jin-Moo Lee,Andria L. Ford
THROMBOSIS AND HEMOSTASIS
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
Clinical Trials & Observations
Wolfgang Miesbach,Karina Meijer,Michiel Coppens,Peter Kampmann,Robert Klamroth,Roger Schutgens,Marco Tangelder,Giancarlo Castaman,Joachim Schwäble,Halvard Bonig,Erhard Seifried,Federica Cattaneo,Christian Meyer,Frank W. G. Leebeek
LETTER TO BLOOD
BLOOD WORK
ERRATUM
-
Cover Image
Cover Image
The interaction between Nbeal2 and Vac14 is illustrated by a proximity ligation assay where red dots indicate such interaction. Megakaryocytes are counterstained with phalloidin (green) and DAPI (4',6-diamidino-2-phenylindole; blue) to allow their visualization. See the article by Mayer et al on page 1000.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals